Charles Peterson, MD
Orthopaedic Surgery · Seattle, WANPI 1851350680
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (45.3%), food and beverage and education — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Smith+Nephew at 58.5% of the total.
Across 24 payments — averaging $197.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$3K
- Summit Surgical Corp.$1K
- AbbVie$260
- Responsive Arthroscopy Inc$200
- Johnson & Johnson$135
- Medical Device Business Services, Inc.$112
- plus $62 from 2 others
Across 7 payments — averaging $9113.00 each. An ownership or investment interest held by the physician or an immediate family member.
- Responsive Arthroscopy Inc$64K
What the payments were for
- Travel & lodging$2,14845%
- Food & beverage$1,39529%
- Education$1,20025%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 15 | $2,772 |
| Summit Surgical Corp. | 1 | $1,200 |
| AbbVie | 2 | $260 |
| Responsive Arthroscopy Inc | 1 | $200 |
| Johnson & Johnson | 2 | $135 |
| Medical Device Business Services, Inc. | 1 | $112 |
| Zimmer Biomet | 1 | $38 |
| Stryker | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OR3O Dual Mobility$1,754
- RI.HIP NAVIGATION$1,754
- JOURNEY$1,754
- POLARSTEM$1,282
- REAL INTELLIGENCE$801
- Tandem$472
- Journey II$424
- R3 ACETABULAR$227
- EXPAREL$112
How this compares
$4,742 in reported general payments places this provider in the 60th percentile of 495 orthopaedic surgery providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 16 | $109 |
| Meloxicam | 29 | $73 |
| Tramadol Hcl | 21 | $68 |
| Amoxicillin | 26 | $49 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Seattle
- James PritchettSeattle$6.4M
- James CrutcherSeattle$3.5M
- Keith MayoSeattle$3.1M
- Matthew SaltzmanSeattle$1.8M
- Burt YaszaySeattle$1.3M
- Sean ToomeySeattle$1.2M
- Robert HartSeattle$942K
- Jeffrey RohSeattle$604K
- Michael BrageSeattle$496K
- Daniel SchwartzSeattle$424K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.